Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer
Publication date
2018-03-01
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Classical cadherins are the key molecules that control cell-cell adhesion. Notwithstanding this function, it is also clear that classical cadherins are more than just the "glue" that keeps the cells together. Cadherins are essential regulators of tissue homeostasis that govern multiple facets of cellular function and development, by transducing adhesive signals to a complex network of signaling effectors and transcriptional programs. In cancer, cadherins are often inactivated or functionally inhibited, resulting in disease development and/or progression. This review focuses on E-cadherin and its causal role in the development and progression of breast and gastric cancer. We provide a summary of the biochemical consequences and consider the conceptual impact of early (mutational) E-cadherin loss in cancer. We advocate that carcinomas driven by E-cadherin loss should be considered "actin-diseases," caused by the specific disruption of the E-cadherin-actin connection and a subsequent dependence on sustained actomyosin contraction for tumor progression. Based on the available data from mouse and human studies we discuss opportunities for targeted clinical intervention
Keywords
Animals, Breast Neoplasms/etiology, Cadherins/physiology, Cell Adhesion, Disease Progression, Epithelial-Mesenchymal Transition, Female, Humans, Mammary Glands, Human/physiology, Stomach Neoplasms/etiology, Tumor Suppressor Protein p53/physiology, Taverne, General Biochemistry,Genetics and Molecular Biology, Journal Article, Review, Research Support, Non-U.S. Gov't
Citation
Bruner, H C & Derksen, PWB 2018, 'Loss of E-Cadherin-Dependent Cell-Cell Adhesion and the Development and Progression of Cancer', Cold Spring Harbor Perspectives in Biology, vol. 10, no. 3, a029330. https://doi.org/10.1101/cshperspect.a029330